Vivek Verma

Active 1999–2026

242
Papers
20,243
Citations
78
h-index
214
i10-index

Citations

Citations per year for Vivek Verma1984: 1 citations1987: 1 citations1998: 1 citations2000: 12 citations2001: 15 citations2002: 10 citations2003: 10 citations2004: 18 citations2005: 16 citations2006: 9 citations2007: 20 citations2008: 14 citations2009: 38 citations2010: 42 citations2011: 39 citations2012: 59 citations2013: 48 citations2014: 43 citations2015: 40 citations2016: 63 citations2017: 93 citations2018: 117 citations2019: 468 citations2020: 813 citations2021: 952 citations2022: 870 citations2023: 777 citations2024: 1,212 citations2025: 617 citations2026: 54 citations1985–1986: no citations, so these years are not shown1988–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,766 citing papers, 20.2% of this breakdownChina: 1,682 citing papers, 19.2% of this breakdownGermany: 438 citing papers, 5% of this breakdownUnited Kingdom: 381 citing papers, 4.3% of this breakdownIndia: 373 citing papers, 4.3% of this breakdownCanada: 333 citing papers, 3.8% of this breakdownItaly: 321 citing papers, 3.7% of this breakdownFrance: 264 citing papers, 3% of this breakdownNetherlands: 227 citing papers, 2.6% of this breakdownAustralia: 199 citing papers, 2.3% of this breakdownSouth Korea: 184 citing papers, 2.1% of this breakdownSpain: 177 citing papers, 2% of this breakdown
0%20.2%Other 27.5%

Fields

  • Medicine48.3%
  • Biochemistry, Genetics and Molecular Biology12.6%
  • Computer Science8.4%
  • Agricultural and Biological Sciences7.2%
  • Engineering5.7%
  • Environmental Science5.5%
  • Other12.3%

Topics

  • Cancer Immunotherapy and Biomarkers5%
  • Lung Cancer Diagnosis and Treatment2.2%
  • Immunotherapy and Immune Responses2.1%
  • Lung Cancer Research Studies1.7%
  • Advanced Radiotherapy Techniques1.6%
  • Lung Cancer Treatments and Mutations1.6%
  • Other85.8%

Coauthors

All papers

Open in search
  1. Plant hormone-mediated regulation of stress responses

    Authors: , , - BMC Plant Biology 2016 cited by 2,242

  2. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2020 cited by 558

  3. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 224

  4. Ghostbuster: Detecting Text Ghostwritten by Large Language Models

    Authors: , , , - Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies (Volume 1: Long Papers), NAACL-HLT 2024 cited by 68

  5. Acute inflammatory response via neutrophil activation protects against the development of chronic pain

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2022 cited by 329

  6. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2019 cited by 333

  7. Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Zeng - JNCI Journal of the National Cancer Institute 2022 cited by 255

  8. MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 180

  9. Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy

    Authors: , , , , , - Breast Cancer Research and Treatment 2018 cited by 388

  10. Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

    Authors: , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 cited by 287

  11. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Song Gao, Julianne Pollard‐Larkin, P Nitsch, R Sadagopan, Xiaochun Wang - The Lancet Oncology 2021 cited by 312

  12. A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors

    Authors: , , , , , , - Journal for ImmunoTherapy of Cancer 2018 cited by 319

  13. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury

    Authors: , , , , , , - Frontiers in Immunology 2021 cited by 99

  14. Quantum image encryption algorithm based on 3D-BNM chaotic map

    Authors: , - Nonlinear Dynamics 2024 cited by 62

  15. Biodegradable Materials for Bone Repair and Tissue Engineering Applications

    Authors: , , , , , - Materials 2015 cited by 778

  16. Fibromyalgia patients with elevated levels of anti–satellite glia cell immunoglobulin G antibodies present with more severe symptoms

    Authors: , , , , , , , , , , , , , - Pain 2023 cited by 80

  17. Plant Nutrition: An Effective Way to Alleviate Abiotic Stress in Agricultural Crops

    Authors: , , , , , , , , , - International Journal of Molecular Sciences 2022 cited by 332

  18. Ultraviolet Radiations: Skin Defense-Damage Mechanism

    Authors: , , , , , , , , - Advances in experimental medicine and biology 2017 cited by 259

  19. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

    Authors: , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 cited by 96

  20. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy

    Authors: , , , , , , , , , , - Radiotherapy and Oncology 2018 cited by 258

  21. Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David S. Hong - Cancer Immunology Research 2019 cited by 146

  22. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baohua Sun, María Angélica Cortez, James W. Welsh - Radiotherapy and Oncology 2021 cited by 92

  23. Depth from motion for smartphone AR

    Authors: , , , , , , , , , , , , , , , , , , , , - ACM Transactions on Graphics, ACM Trans. Graph. 2018 cited by 114

  24. Adipose-Derived Stem Cells (ADSCs) Loaded Gelatin-Sericin-Laminin Cryogels for Tissue Regeneration in Diabetic Wounds

    Authors: , , , - Biomacromolecules 2019 cited by 79